歐盟MDR自2017年5月25日發布後,緩衝期三年後即2020年5月26日執行,表示廠商明年5月後只能遵守MDR要求,廠商第一步應開始評估產品在MDR要求下是符合哪一個分類分級,而原先MDD的Classification Rules有18個到了MDR則變成了22個,擴增了4個,包括使用奈米材料的醫材、純軟體醫材等,分類分級如列表,確認了產品等級後才能進一步確認MDR申請符合的路徑。
Non Invasive Devices |
Classification |
Rule 1 |
|
Devices that either do not touch patient or contact only intact skin |
I |
Rule 2 |
|
Channelling or storing blood, body liquids, cells or tissues, liquids or gases for the purpose of eventual infusion, administration or introduction into the body |
|
|
IIa |
|
IIa |
The devices are intended for use for blood bags. |
IIb |
In all other cases |
I |
Rule 3 |
|
Modifying the biological or chemical composition of human tissues or cells, blood, other body liquids or other liquids intended for implantation or administration into the body |
IIb |
|
IIa |
The devices consisting of a substance or a mixture of substances intended to be used in vitro in direct contact with human cells, tissues or organs taken from the human body or used in vitro with human embryos before their implantation or administration into the body |
III |
Rule 4 |
|
In contact with injured skin or mucous membrane |
|
|
I |
|
IIb |
|
IIa |
|
IIa |
This rule applies also to the invasive devices that come into contact with injured mucous membrane. |
Invasive Devices |
Classification |
Rule 5 Invasive in body orifice or stoma (Not Surgically) |
|
All invasive devices with respect to body orifices, other than surgically invasive devices, which are not intended for connection to an active device or which are intended for connection to a class I active device |
I |
|
I |
|
IIa |
|
I |
|
IIb |
|
IIa |
All invasive devices with respect to body orifices, other than surgically invasive devices, intended for connection to a class IIa, class IIb or class III active device |
IIa |
Rule 6 Surgically invasive devices for transient use (< 60 minutes) |
|
All surgically invasive devices intended for transient use |
IIa |
|
III |
|
I |
|
III |
|
IIb |
|
IIb |
|
IIb |
Rule 7 Surgically invasive devices for short-term use (>60 minutes, <30 days) |
|
All surgically invasive devices intended for short-term use |
IIa |
|
III |
|
III |
|
IIb |
|
III |
|
IIb |
Rule 8 Implantable devices and long-term surgically invasive devices (> 30 days) |
|
All implantable devices and long-term surgically invasive devices |
IIb |
|
IIa |
|
III |
|
III |
|
III |
|
III |
|
III |
|
III |
|
III |
|
III |
Active Devices |
Classification |
Rule 9 |
|
All active therapeutic devices intended to administer or exchange energy |
IIa |
|
IIb |
All active devices intended to control or monitor the performance of active therapeutic class IIb devices, or intended directly to influence the performance of such devices |
IIb |
All active devices intended to emit ionizing radiation for therapeutic purposes, including devices which control or monitor such devices, or which directly influence their performance |
IIb |
All active devices that are intended for controlling, monitoring or directly influencing the performance of active implantable devices |
III |
Rule 10 |
|
Active devices intended for diagnosis and monitoring
|
IIa |
Active devices intended to illuminate the patient's body, in the visible spectrum |
I |
Active devices are specifically intended for monitoring of vital physiological parameters and the nature of variations of those parameters is such that it could result in immediate danger to the patient, for instance variations in cardiac performance, respiration, activity of the central nervous system, or they are intended for diagnosis in clinical situations where the patient is in immediate danger |
IIb |
Active devices intended to emit ionizing radiation and intended for diagnostic or therapeutic radiology, including interventional radiology devices and devices which control or monitor such devices, or which directly influence their performance |
IIb |
Rule 11 (NEW) |
|
Software intended to provide information which is used to take decisions with diagnosis or therapeutic purposes |
IIa |
|
III |
|
IIb |
Software intended to monitor physiological processes |
IIa |
|
IIb |
All other software |
I |
Rule 12 |
|
All active devices intended to administer and/or remove medicinal products, body liquids or other substances to or from the body |
IIa |
|
IIb |
Rule 13 |
|
All other active devices |
I |
Special Rules |
Classification |
Rule 14 |
|
All devices incorporating, as an integral part, a substance which, if used separately, can be considered to be a medicinal product, as defined in point 2 of Article 1 of Directive 2001/83/EC, including a medicinal product derived from human blood or human plasma, as defined in point 10 of Article 1 of that Directive, and that has an action ancillary to that of the devices |
III |
Rule 15 |
|
All devices used for contraception or prevention of the transmission of sexually transmitted diseases |
IIb |
|
III |
Rule 16 |
|
All devices intended specifically to be used for disinfecting, cleaning, rinsing or, where appropriate, hydrating contact lenses |
IIb |
All devices intended specifically to be used for disinfecting or sterilising medical devices |
IIa |
|
IIb |
This rule does not apply to devices that are intended to clean devices other than contact lenses by means of physical action only. |
|
Rule 17 |
|
Devices specifically intended for recording of diagnostic images generated by X-ray radiation |
IIa |
Rule 18 |
|
All devices manufactured utilising tissues or cells of human or animal origin, or their derivatives, which are non- viable or rendered non-viable, unless such devices are manufactured utilising tissues or cells of animal origin, or their derivatives, which are non-viable or rendered non-viable and are devices intended to come into contact with intact skin only |
III |
Rule 19 (New) |
|
All devices incorporating or consisting of nanomaterial |
|
|
III |
|
IIb |
|
IIa |
Rule 20 (New) |
|
All invasive devices with respect to body orifices, other than surgically invasive devices, which are intended to administer medicinal products by inhalation |
IIa |
|
IIb |
Rule 21 (New) |
|
Devices that are composed of substances or of combinations of substances that are intended to be introduced into the human body via a body orifice or applied to the skin and that are absorbed by or locally dispersed in the human body |
|
|
III |
|
III |
|
IIa |
|
IIb |
Rule 22 (New) |
|
Active therapeutic devices with an integrated or incorporated diagnostic function which significantly determines the patient management by the device, such as closed loop systems or automated external defibrillators |
III |
留言列表